Naloxone Accord (Naloxone Hydrochloride)

Naloxone is an opioid antagonist used in the management of opioid overdose and related conditions.

• Opioid overdose: restores normal respiration and consciousness by displacing opioids from μ‑receptors.
• Opioid‑induced respiratory depression: rapidly reverses life‑threatening respiratory depression.
• Opioid toxicity: counteracts central nervous system depression and sedation caused by opioid exposure.

• Naloxone acts as a competitive antagonist at μ, κ and δ opioid receptors. By binding to these receptors without activating them, it displaces opioid agonists such as morphine, fentanyl or heroin, thereby reversing their pharmacologic effects on respiratory drive, analgesia, and central nervous system depression.

Naloxone may cause a range of adverse reactions after administration.

Common Side Effects

• Injection site pain: mild discomfort at the site of intravenous administration.
• Nausea: transient feeling of queasiness.
• Sweating: increased perspiration.

Serious or Rare Side Effects

• Acute pulmonary edema: sudden fluid accumulation in the lungs.
• Seizures: convulsive episodes, especially in patients with pre‑existing seizure disorders.
• Anaphylaxis: severe allergic reaction requiring immediate medical intervention.

Naloxone should be used with careful clinical assessment and monitoring.

• Assess airway and breathing: confirm opioid‑induced respiratory compromise before administration.
• Monitor cardiovascular status: watch for hypertension or tachycardia after dosing.
• Consider opioid dependence: abrupt reversal may precipitate withdrawal symptoms.
• Avoid in patients with known hypersensitivity to naloxone.
• Pregnancy: use only if the anticipated benefit outweighs potential risk, as safety data are limited.
• Store at ambient temperature: keep in the original container, protect from light and moisture.

Naloxone may interact with other medications that affect the central nervous or cardiovascular systems.

Major Interactions (Avoid)

• Potent opioids (e.g., fentanyl): may require higher naloxone doses for effective reversal.
• Drugs that lower seizure threshold: concurrent use can increase seizure risk.
• Vasopressors: may mask hypotension caused by opioid toxicity.

Moderate Interactions (Monitor Closely)

• Benzodiazepines: may need additional support for residual sedation.
• Anticholinergics: monitor for additive cardiovascular effects.
• Cardiac glycosides: observe for potential arrhythmias during reversal.